Hetrombopag Uses, Dosage, Side Effects and more
Hetrombopag is under investigation in clinical trial NCT03976882 (Hetrombopag for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Malignancy.).
Trade Name | Hetrombopag |
Generic | Hetrombopag |
Type | |
Formula | C25H22N4O5 |
Weight | Average: 458.474 Monoisotopic: 458.159019824 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |